Tag Archive | "ISIS"

Industry Updates

Genzyme and Isis Report Positive Results for Cholesterol-Lowering Drug, Liver Safety Issue Lingers | Xconomy11 Feb

Local biotech Isis Pharmaceuticals reports strong results for their cholesterol therapy mipomersen, at the same time broadening potential patients from those that are homozygous for familial hypercholesterolemia to those who are heterozygous as well. Isis and partner Genzyme plan to move this treatment to market in 2011. http://www.xconomy.com/boston/2010/02/10/genzyme-and-isis-report-positive-results-for-cholesterol-lowering-drug/
Industry Updates

Isis cholesterol drug hits bulls-eye in pivotal trial – FierceBiotech17 Nov

A spectacular result for local biotech Isis Pharmaceuticals with their cholesterol candidate mipomercen. This trial saw an average 25% reduction in LDL for genetically suseptible patients, with some seeing reductions of 70 – 80%. That’s great news for Isis and marketing partner Genzyme. http://www.fiercebiotech.com/story/isis-cholesterol-drug-hits-bulls-eye-pivotal-trial/2009-11-17?utm_medium=nl&utm_source=internal

Company News

  • - 2013/03/04

    One of our team members is now working with Hospira on infuser product support. Contact us to find out more!

  • - 2010/10/24

    We're currently working with online elections provider Everyone Counts, Inc. Contact us to find out more!

Contact Us